CAPSOVISION, INC

Profile

Company Names

CAPSOVISION, INC
CAPSO VISION INC

Addresses

18805 COX AVENUE SUITE 250, SARATOGA, CA 95070

Phone Numbers

(408) 370-4790

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$112,683,966.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2020-05-21 
$980,000.00 
$5,470,000.00 
$4,490,000.00 
Debt 
12
2019-11-21 
$64,828,822.00 
$64,828,840.00 
$18.00 
Equity 
11
2018-08-16 
$6,058,958.00 
$10,000,000.00 
$3,941,042.00 
Equity 
10
2018-01-05 
$8,000,009.00 
$8,000,100.00 
$91.00 
Equity 
9
2016-03-02 
$4,599,999.00 
$15,000,000.00 
$10,400,001.00 
Equity 
8
2014-01-23 
$15,899,997.00 
$16,100,000.00 
$200,003.00 
Equity 
7
2012-10-09 
$3,707,200.00 
$3,707,200.00 
$0.00 
Equity 
6
2012-08-20 
$450,000.00 
$700,000.00 
$250,000.00 
Debt 
5
2012-06-12 
$589,993.00 
$6,089,999.00 
$5,500,006.00 
Equity 
4
2011-12-22 
$1,459,997.00 
$1,999,999.00 
$540,002.00 
Equity 
3
2011-01-31 
$2,514,993.00 
$3,450,000.00 
$935,007.00 
Equity 
2
2010-02-12 
$2,549,989.00 
$5,000,000.00 
$2,450,011.00 
Equity 
1
2009-07-28 
$1,044,009.00 
$1,044,009.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
M L 
 
CHEN 
DIRECTOR
M.L. 
 
CHEN 
DIRECTOR
PETER 
 
CHOU 
DIRECTOR
HEIDI 
 
CHUNG 
DIRECTOR
WEILI 
 
DAI 
DIRECTOR
ELI 
 
HARARI 
DIRECTOR
H.L. 
 
HSIEH 
DIRECTOR
HUNG 
 
HSIEH 
DIRECTOR
HUNG LIANG 
 
HSIEH 
DIRECTOR
CHUNG 
 
HSU 
DIRECTOR
PATTY 
 
KUO 
DIRECTOR
MATTHEW 
 
LIU 
DIRECTOR
MORRIS 
 
LU 
DIRECTOR
LEN 
 
MEI 
DIRECTOR
CHEN 
 
TSAI 
DIRECTOR
WEN-HUNG 
 
TSAI 
DIRECTOR
PEN-JUNG 
 
TSENG 
DIRECTOR
KANG 
HUAI 
WANG 
EXECUTIVE OFFICER, DIRECTOR
HSIU-HSIEN 
 
WU 
DIRECTOR
MINTZE 
 
WU 
DIRECTOR
SHIH-CHANG 
 
WU 
DIRECTOR
STEPHEN S. C. 
 
WU 
DIRECTOR
YING-HUI 
 
WU 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#